All News #Library
Rare Diseases
Atossa Pharma Sustains (Z)-Endoxifen Dominance In DMD
05 Feb 2026 //
PR NEWSWIRE
Atossa Pharma Gets FDA Orphan Status For (Z)-Endoxifen
16 Jan 2026 //
PR NEWSWIRE
Atossa Pharma Gets FDA Rare Pediatric Disease Status For DMD
11 Dec 2025 //
PR NEWSWIRE

Market Place
Sourcing Support